Healio

Fitusiran prophylaxis superior to on-demand treatment for severe hemophilia

Please provide your email address to receive an email when new articles are posted on . Once-monthly fitusiran prophylaxis improved outcomes compared with on-demand treatment for patients with severe ...
The American Journal of Managed Care

Prophylactic Treatment Challenges and Considerations for Hemophilia A

Allison Wheeler, MD, delves into the complexities of prophylaxis for mild to moderate hemophilia A cases, exploring a patient-centric approach, situational prophylaxis during high-risk activities, and ...
ascopubs.org

Podcast: VTE Prophylaxis and Treatment in Patients with Cancer Guideline Update

Dr. Nigel Key and Dr. Anna Falanga join us for a conversation on the updated ASCO VTE prophylaxis and treatment in patients with cancer guideline. They discuss recent evidence assessing apixaban for ...
Healio

Concizumab prophylaxis reduces bleeds in hemophilia population ‘with complex treatment needs’

Please provide your email address to receive an email when new articles are posted on . Patients who received prophylactic concizumab had a mean overall annualized bleeding rate of zero compared with ...
Nasdaq

Novo Nordisk A/S: Mim8 prophylaxis treatment shown to be well-tolerated when switching from emicizumab in people with haemophilia A in new phase 3 data presented at the ISTH ...

New FRONTIER5 data show that a direct switch to investigational Mim8 (denecimig) prophylaxis treatment from emicizumab, without the need for a washout period, was well-tolerated with no safety ...
MPR

FRONTIER2: Denecimig Prophylaxis Reduces Treated Bleeds in Hemophilia A

Novo Nordisk submitted a BLA to the Food and Drug Administration for denecimig for the treatment of hemophilia A in September 2025.
The American Journal of Managed Care

Study Summary: Migraine Prophylaxis and Risk of Cardiovascular Events, Cerebrovascular Events, and Mortality

Author(s)Hoffman V, Xue F, Ezzy SM, et al. Risk of cardiovascular, cerebrovascular events and mortality in patients with migraine receiving prophylactic treatments: an observational cohort study ...